Evidence map›Paper›PMID 41409666›Full record

ArticlemedRxiv : the preprint server for health sciences2025

High Frequency and Unique Subtypes of Meningioma in Patients with BAP1 Tumor Predisposition Syndrome.

Kaylee A Ramsey, Lindsey Byrne, Olivia B Taylor, Amr Soliman, Emma Schreiner, Isabella Gray, Alicia Latham, Rania Sheikh, Saman S Ahmadian, Russell R Lonser and 4 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Kaylee A RamseyHavener Eye Institute, Department of Ophthalmology and Visual Sciences, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Lindsey ByrneDivision of Human Genetics, Department of Internal Medicine, The Ohio State University Columbus, Columbus, OH, USA.ORCID 0000-0001-7131-5331
Olivia B TaylorHavener Eye Institute, Department of Ophthalmology and Visual Sciences, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID 0009-0002-6827-0552
Amr SolimanHavener Eye Institute, Department of Ophthalmology and Visual Sciences, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Emma SchreinerHavener Eye Institute, Department of Ophthalmology and Visual Sciences, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Isabella GrayHavener Eye Institute, Department of Ophthalmology and Visual Sciences, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Alicia LathamDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Rania SheikhDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Saman S AhmadianDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID 0000-0002-4133-7895
Russell R LonserDepartment of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Joshua D PalmerDepartment of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID 0000-0003-3311-0129
Maria I CarloDepartment of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-4786-7408
Colleen M CebullaHavener Eye Institute, Department of Ophthalmology and Visual Sciences, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID 0000-0002-5636-4968
Mohamed H Abdel-RahmanHavener Eye Institute, Department of Ophthalmology and Visual Sciences, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID 0000-0002-9493-7894

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
The Ohio State University Center for Clinical and Translational Science (UL1)UL1TR000090 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$7.9M
The Ohio State University Vision Sciences Research Core Program (OSU-VSRCP)P30EY032857 · NEI · OHIO STATE UNIVERSITY · PI Sayoko E Moroi · 2022 to 2026
$3.6M
Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)R01CA255323 · NCI · OHIO STATE UNIVERSITY · PI ABDEL-RAHMAN, MOHAMED H. · 2021 to 2025
$2.9M
Investigating the Role of KEAP1 Germline and Somatic Mutations in Renal Cell CarcinomaK08CA272960 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Maria Carlo · 2023 to 2026
$1.1M
NCATS NIH HHS UL1 TR000090NCI NIH HHS K08 CA272960NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA255323NEI NIH HHS P30 EY032857
6 · The paper itself

Abstract

Background: Methods: We conducted a retrospective chart review of meningiomas in two independent cohorts of patients with germline Results: In a cohort of 237 subjects with Conclusions: This study provides additional evidence that high-grade brain and spinal meningiomas are part of the clinical spectrum of

Indexed as

BAP1BAP1-TPDSBAP1 Tumor Predisposition SyndromeBRCA Associated Protein-1Meningioma

Identifiers

PMID41409666
PMCPMC12706622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.